Matthew Kowalski

Matthew Kowalski discloses dealings in MustGrow Biologics Corp. to SEDI. The record holds 3 filings, for trades running from 31 May 2018 to 15 December 2023.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 19 December 2023: a transaction, in MustGrow Biologics Corp. Typically, a trade is published a median of 15 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.